Novartis Vanrafia Phase III data support slowing of kidney function decline in patients with IgA nephropathy
Basel, February 13, 2026 – Novartis today announced final results from the…
PUNO Unveils Pune's First Social Zone at PUNO Advance
PUNO, a fast-growing experiential entertainment brand, today announced the launch of its…
U.S. FDA Approves Agios AQVESME (mitapivat) for the Treatment of Anemia in Adults with Alpha- or Beta-Thalassemia
AQVESME is the only FDA-approved medicine for anemia in both non-transfusion-dependent and…
Milestone Receives FDA Approval of CARDAMYST (etripamil) as First and Only Self-Administered Nasal Spray for Adults with Paroxysmal Supraventricular Tachycardia (PSVT)
First FDA approved treatment in 30+ years for more than 2 million…
UCB presents positive results from GEMZ phase 3 study at AES showing fenfluramine significantly reduces countable motor seizure frequency in CDKL5 Deficiency Disorder
Seizure reduction: phase 3 study achieved primary endpoint as fenfluramine demonstrated a…
THE U.S. POINTER STRUCTURED HEALTHY LIFESTYLE PROGRAM — PREVIOUSLY SHOWN TO IMPROVE COGNITION — MAY ALSO IMPROVE SLEEP APNEA, BLOOD PRESSURE REGULATION, AND COGNITIVE RESILIENCE
- Two-year lifestyle intervention "recipe" tested in three NIH-funded ancillary studies -Key…
Memory Lift Launches Revolutionary Brain Booster: The Truth About the Memory Lift Nootropics Supplement
New York City, NY, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Â Memory Lift…
Rendever Receives Nearly $4.5 Million in NIH Funding to Overcome Social Isolation for Older Adults while Supporting Caregivers
BOSTON, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Rendever, the company leading the…
Derila Ergo Pillow Reviews Real Results, Benefits, Side Effects & Why the Derila Pillow Is Worth It for Pain-Free Sleep
New York City, NY, Nov. 01, 2025 (GLOBE NEWSWIRE) -- Introduction –…
Sanofi Hosts Regional Webinar on Protecting High-Risk Groups from Seasonal Influenza
Sanofi recently hosted a hybrid symposium titled "Safeguarding High-Risk Groups: The Importance…